相关实验视频
Updated: Jul 9, 2025
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.1K
在炎症性肠道疾病中肠道微生物群的特征
Marie Vibeke Vestergaard1, Kristine H Allin1,2, Carsten Eriksen1,3
1Center for Molecular Prediction of Inflammatory Bowel Disease, PREDICT, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark.
United European gastroenterology journal
|December 2, 2023
概括
这项研究分析了来自45个队伍的肠道微生物群数据,确定了许多与炎症性肠道疾病 (IBD) 相关的细菌属,包括克罗恩病 (CD) 和性结肠炎 (UC). 这些发现为IBD治疗提供了潜在的新点.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 基因组学就是基因组学.
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),代表着日益严重的全球健康问题.
- 现有的研究表明,肠道微生物群和IBD之间存在联系,但往往受到有限的样本大小的影响.
- 本研究通过重新分析来自IBD患者便微生物群的大型,公开可用的数据集来解决这些局限性.
研究的目的:
- 对来自炎症性肠病 (IBD) 患者的便微生物群数据进行全面的元分析.
- 通过整合来自多个队伍的数据来识别与克罗恩病 (CD) 和性结肠炎 (UC) 相关的特定微生物特征.
- 发现与IBD相关的新细菌属,并评估这些关联在各种数据集和技术平台上的稳定性.
主要方法:
- 通过NCBI BioProject数据库从45个IBD患者和健康对照组提取了16SrRNA扩增序列数据.
- 将所有队列的数据合并到一个单一的,全面的数据集中,包括人口统计和临床信息,同时考虑到平台的变化.
- 分析了微生物群的特征,包括α和β多样性,并确定了相关的细菌属.
主要成果:
- 确定了大量与IBD相关的细菌属,包括77种CD (38种新型) 和64种UC (28种新型).
- 在不同的技术平台和地理位置观察到强大的协会.
- 与健康对照组相比,IBD患者的α多样性减少,UC和特别是CD的β多样性明显改变.
结论:
- 这项大规模的元分析确定了大量与IBD相关的细菌属.
- 确定了与CD和UC密切相关的微生物群特征,可以作为关键生物标志物.
- 这些发现对开发针对IBD肠道微生物组的新型治疗策略充满希望.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
190
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
190
01:30Inflammatory Bowel Disease II: Crohn's Disease
255
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
255
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
335
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335
01:17Irritable Bowel Syndrome I: Introduction
280
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
280
01:17Chronic Bowel Disorders: Introduction
456
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
456
01:29Inflammatory Bowel Disease IV: Pharmacological Management
130
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
130